ConductScience.org, home

Paper40156757

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.

Gjølberg TT and 5 others. BioDrugs, 2025. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress. Papers, record 40156757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40156757

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.
PubMed
Journal
BioDrugs
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
6.69, provisional
iCite
Revised in PubMed
2025-04-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gjølberg TTTorleif Tollefsrudhttps://orcid.org/0000-0002-1719-7677
2Mester SSimonehttps://orcid.org/0000-0002-5751-063X
3Calamera GGaiahttps://orcid.org/0000-0003-0689-8387
4Telstad JSJenny Skjermo
5Sandlie IIngerhttps://orcid.org/0009-0005-8063-0145
6Andersen JTJan Terjehttps://orcid.org/0000-0003-1710-1628

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, FcMajor topic
Histocompatibility Antigens Class IMajor topic
Autoimmune DiseasesMajor topic
Humans
Animals
Immunoglobulin G
Autoantibodies

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
333902Norges ForskningsrådPubMed
332727Norges ForskningsrådPubMed
0090894Novo Nordisk FoundationPubMed

Source PubMed

Download CSV of grants

References357

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133742786Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers.Clin Transl Sci2021https://conductscience.org/library/papers/33742786PubMed
215682382Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions.J Pharm Sci2005https://conductscience.org/library/papers/15682382PubMed
331354709The Neonatal Fc Receptor (FcRn): A Misnomer?Front Immunol2019https://conductscience.org/library/papers/31354709PubMed
433452006Novel autoantibodies identified in ACPA-negative rheumatoid arthritis.Ann Rheum Dis2021https://conductscience.org/library/papers/33452006PubMed
532797372Satralizumab: First Approval.Drugs2020https://conductscience.org/library/papers/32797372PubMed
6302837352018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.Eur Thyroid J2018https://conductscience.org/library/papers/30283735PubMed
78125126Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.Eur J Immunol1994https://conductscience.org/library/papers/8125126PubMed
824373505A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.J Autoimmun2014https://conductscience.org/library/papers/24373505PubMed
922110902Juvenile myasthenia gravis: a paediatric perspective.Autoimmune Dis2011https://conductscience.org/library/papers/22110902PubMed
1028062799A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life.Mol Cell Proteomics2017https://conductscience.org/library/papers/28062799PubMed
1116908486Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.N Engl J Med2006https://conductscience.org/library/papers/16908486PubMed
1212794168Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.J Immunol2003https://conductscience.org/library/papers/12794168PubMed
137969491Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.Nature1994https://conductscience.org/library/papers/7969491PubMed
1420581680Acquired myasthenia gravis in childhood.Curr Opin Neurol2010https://conductscience.org/library/papers/20581680PubMed
1523829325H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.Transfusion2014https://conductscience.org/library/papers/23829325PubMed
1633219142Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.Neurology2021https://conductscience.org/library/papers/33219142PubMed
1732795110Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity.MAbs2020https://conductscience.org/library/papers/32795110PubMed
1839674966Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis.Immunol Res2024https://conductscience.org/library/papers/39674966PubMed
192107806Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.Arthritis Rheum1990https://conductscience.org/library/papers/2107806PubMed
2030130439Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.MAbs2018https://conductscience.org/library/papers/30130439PubMed

See all 357 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42729864Structure and function of therapeutic antibodies approved by the US FDA in 2025.Antib Ther2026https://conductscience.org/library/papers/42729864PubMed
42534577Novel biopharmaceutical strategies: Fc-fusion protein technology.Front Pharmacol2026https://conductscience.org/library/papers/42534577PubMed
42430031Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention.Curr HIV/AIDS Rep2026https://conductscience.org/library/papers/42430031PubMed
42388397Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.Ther Adv Neurol Disord2026https://conductscience.org/library/papers/42388397PubMed
42257855Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases.Inflamm Res2026https://conductscience.org/library/papers/42257855PubMed
42162557Depletion and recovery of IgG following treatment with an anti-FcRn antibody and IdeS in pigtail macaques.Clin Exp Immunol2026https://conductscience.org/library/papers/42162557PubMed
41880580Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41880580PubMed
41742631Systemic Manifestations of Neonatal Lupus in an Infant Born to an Asymptomatic Mother: A Case Report of Anemia and Transaminitis.Am J Case Rep2026https://conductscience.org/library/papers/41742631PubMed
41598737Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.J Clin Med2026https://conductscience.org/library/papers/41598737PubMed
41590994Precision Immunomodulation in Pregnancy - Lessons from Nipocalimab.NEJM Evid2026https://conductscience.org/library/papers/41590994PubMed
41304800Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies?Pharmaceutics2025https://conductscience.org/library/papers/41304800PubMed
41292880Depletion and recovery of IgG following treatment with Rozanoliximab and Imlifidase in pigtail macaques.bioRxiv2025https://conductscience.org/library/papers/41292880PubMed
41246121Advancing the Therapeutic Frontier in Thyroid Eye Disease.touchREV Endocrinol2025https://conductscience.org/library/papers/41246121PubMed
40843677FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia.Antibodies (Basel)2025https://conductscience.org/library/papers/40843677PubMed
40824232Evaluation of Immune Functions in Transfusion-Dependent Thalassemia Patients with AlloimmunizationTurk J Haematol2025https://conductscience.org/library/papers/40824232PubMed
40821792The FcRn from gene to protein and function: comparison between species.Front Immunol2025https://conductscience.org/library/papers/40821792PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
FCGRT2217PubTator's text mininghttps://conductscience.org/library/genes/2217NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40156757

GET https://conductscience.org/api/papers/v1/40156757/references?page=2